Military Veterans Join Virtue Recovery to Expand Community Outreach With Hope and Support
Virtue Recovery has expanded its Business Development Team with the addition of two American Veterans, Adam Khosroabadi and Chauncy Nash....
Veterans
TempraMed Closes Oversubscribed C$7.4M Financing and Advances Toward Go Public Listing
Sammamish, Washington--(Newsfile Corp. - September 3, 2025) - TempraMed Ltd. ("TempraMed" or the "Company"), a medical technology innovator redefining how...
Homecare Homebase Announces 2025 September Gold Standard Award Winner
DALLAS, Sept. 2, 2025 /PRNewswire/ -- Homecare HomebaseSM (HCHB), the leading software provider for home-based care, today announced Yetagesu (Yeta) Hurisa,...
Taiwan Showcases Smart Healthcare Breakthroughs at Taiwan Expo USA 2025
DALLAS, Aug. 31, 2025 /PRNewswire/ -- At Taiwan Expo USA 2025 in Dallas, the Smart Healthcare Pavilion, organized by the...
Homecare Homebase Advocates for Home Health Agencies with Comment Letter to CMS on 2026 Proposed Rule
HCHB analysis and newly released dashboards reveal the potentially devastating impacts of cuts proposed by CMS, calling for revisions to...
Aegis Ventures Welcomes Healthcare Leaders John Driscoll and Cris Ross as Venture Partners
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Aegis Ventures today announced the appointment of two of healthcare's most accomplished executives...
Groundbreaking Project Analyzes Cell Phone Data from Individuals who Died by Suicide Revealing Unprecedented Insights
RALEIGH, N.C., Aug. 27, 2025 /PRNewswire/ -- Stop Soldier Suicide (SSS) has released the first findings from a pioneering data...
MAPS Partners with Changemark to Advance Cannabis PTSD Research for Veterans
MAPS takes critical step toward beginning formal site selection and recruitment for MJP2, a Phase 2 study of inhaled cannabis...
Dr. Shai Efrati Honored With 2025 Ellis Island Medal of Honor
Hyperbaric oxygen therapy pioneer and Aviv Clinics medical advisor honored for research and service to veterans and patients with stroke,...
Trump Holds the Rescheduling Key: Will Marijuana Reform Follow the Patient’s Right to Try Path?
From ‘Right to Try' to Cannabis: Trump's Next Breakthrough Could Unlock FDA Trials."President Trump's marijuana decision must go beyond politics-patients...
Psyence Group Inc. Enters Into a Letter of Intent to Acquire Goldcoast Resource Corp.
TORONTO, ON / ACCESS Newswire / August 22, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that...
Vera Whole Health and Castlight Health Join Forces with Aligned Marketplace to Expand High-Quality Care Solutions
Strategic partnership expands access to advanced primary care for self-insured employers and unlocks integrated navigation nationwide SEATTLE and NEW YORK,...
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc....
Artera Achieves FedRAMP High “In Process” Status to Support Federal Agencies
Designation Is An Important Milestone In Artera's Journey To Equip Federal Agencies With Secure, AI-Powered Patient Communication Platform and Virtual...
Homecare Homebase Opens Nominations for 2025 Home Care Aide Scholarship Program
The annual scholarship initiative seeks to empower home care aides in their professional advancement, contributing to a highly motivated and...
Red Light Holland Applauds HHS Review of Psilocybin Rescheduling Petition, Expresses Optimism for Reversal of Schedule I Classification
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- San Francisco Bay Area-based crop biotechnology firms genXtraits, Inc. (genXtraits) and Mendel...
First PRIZM Study Participant Enrolled in Tisento Therapeutics’ Open-Label Extension Study in MELAS
Participants Who Complete Treatment in Global Phase 2b PRIZM MELAS Study Are Eligible to EnrollCAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE...
Convoke Raises $8.6M to Build the AI Operating System for Biopharma
Convoke's platform turns raw data into deliverables, helping drug developers accelerate the path from idea to market SOUTH SAN FRANCISCO,...
BDR Solutions and eVisit Partner to Modernize and Transform Military Healthcare Model Delivery with Integrated Digital Capabilities
Partnership to debut at DHITS 2025, turning health data into actionable intelligence to improve readiness and access to care. WASHINGTON,...